Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The development of targeted cancer therapies has revolutionized oncology, offering more effective treatments with fewer side effects. Cabozantinib, a potent multi-tyrosine kinase inhibitor, stands as a testament to these advancements. Its efficacy against various cancers, including medullary thyroid cancer and advanced renal cell carcinoma, is well-documented. Behind this groundbreaking drug lies a series of intricate chemical syntheses, and at its heart is a crucial building block: 6,7-Dimethoxyquinolin-4-ol (CAS 127285-54-5).
Decoding Cabozantinib's Structure and Synthesis
Cabozantinib's complex structure features several key functional components. One of the most critical is the 6,7-dimethoxyquinoline moiety. This heterocyclic core is derived directly from 6,7-Dimethoxyquinolin-4-ol. The synthesis typically involves transforming the hydroxyl group at the 4-position of 6,7-Dimethoxyquinolin-4-ol into a more reactive leaving group, such as a chlorine atom, using reagents like phosphorus oxychloride (POCl₃). This conversion yields 4-chloro-6,7-dimethoxyquinoline.
This activated intermediate then undergoes a nucleophilic aromatic substitution reaction with a substituted phenol or aniline derivative. In the case of Cabozantinib, it reacts with a derivative of 4-aminophenol. This reaction forms a critical ether linkage, connecting the quinoline core to the rest of the molecule. The precise regiochemistry and purity of the starting 6,7-Dimethoxyquinolin-4-ol are paramount to ensure the successful formation of the desired Cabozantinib structure and to avoid impurities.
The Importance of a Reliable 6,7-Dimethoxyquinolin-4-ol Supplier
For pharmaceutical manufacturers and contract research organizations (CROs), securing a consistent supply of high-quality 6,7-Dimethoxyquinolin-4-ol is essential for uninterrupted Cabozantinib production. The complexity of the synthesis demands intermediates that meet strict specifications. NINGBO INNO PHARMCHEM CO.,LTD., as a leading manufacturer and supplier in China, understands these critical requirements. We produce 6,7-Dimethoxyquinolin-4-ol with exceptional purity, ensuring optimal yields and quality in the downstream synthesis of Cabozantinib and other related kinase inhibitors.
Procurement Insights for Your Project
When purchasing 6,7-Dimethoxyquinolin-4-ol, consider the following:
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing pharmaceutical industries worldwide with this vital chemical intermediate. We offer competitive prices and ensure swift delivery, empowering our clients to advance their drug development and manufacturing pipelines efficiently. If you need to buy 6,7-Dimethoxyquinolin-4-ol for your Cabozantinib synthesis or other projects, contact us for a quote and detailed specifications.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
